Imagion Biosystems Limited (ASX:IBX – Get Free Report) insider Brett Mitchell acquired 199,664 shares of the business’s stock in a transaction dated Friday, June 14th. The shares were bought at an average cost of A$0.07 ($0.05) per share, for a total transaction of A$14,775.14 ($9,850.09).
Brett Mitchell also recently made the following trade(s):
- On Monday, June 17th, Brett Mitchell acquired 91,551 shares of Imagion Biosystems stock. The shares were bought at an average cost of A$0.08 ($0.05) per share, for a total transaction of A$7,140.98 ($4,760.65).
- On Wednesday, June 19th, Brett Mitchell acquired 88,569 shares of Imagion Biosystems stock. The shares were bought at an average cost of A$0.09 ($0.06) per share, for a total transaction of A$7,971.21 ($5,314.14).
Imagion Biosystems Stock Performance
The company has a debt-to-equity ratio of 98.44, a current ratio of 0.11 and a quick ratio of 4.04.
About Imagion Biosystems
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer.
Read More
- Five stocks we like better than Imagion Biosystems
- Why is the Ex-Dividend Date Significant to Investors?
- Why Paychex Stock’s Dip is the Best Opportunity in Today’s Cycle
- Trading Halts Explained
- Any Pullback in Tech May Signal a Rotation into These 3 Sectors
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks to Watch: Oracle, Casey’s, FedEx Signal Big Gains
Receive News & Ratings for Imagion Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imagion Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
